In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
Fixtureworks Quick Zero Setting Devices
Fixtureworks® now offers Quick Zero setting devices.
Does Automating Guidewire Testing Improve ROI for Insurance Companies?
The insurance industry is undergoing a rapid digital transformation, making it crucial for insurance companies to implement innovative…
The IMTS 2024 Conference Sessions Announced
IMTS 2024 – The International Manufacturing Technology Show, has announced the full schedule for The IMTS 2024 Conference,…